‘Operation Fly Formula’ aims to tackle the national shortage crisis
A US Air Force C-17 cargo aircraft carrying 78,000 lbs of Nestlé Health Science Alfamino Infant and Alfamino Junior formula from Europe is seen on the tarmac of Indianapolis Airport on May 22, 2022 in Indianapolis, Indiana. © Jon Cherry/Getty Images
The US government has allowed powdered infant milk imports from the UK, the Food and Drug Administration announced in a statement on Tuesday, as the country is grappling with a severe shortage.
British family-owned company Kendal Nutricare will deliver around 2 million cans of Kendamil brand formula to the US by June, the FDA said. According to The Guardian newspaper, 100 truckloads of powdered milk – which was used by the royal family to wean Prince Louis of Cambridge – will be sent.
“We continue to do everything in our power as part of the all-of-government efforts to ensure there’s adequate infant formula available wherever and whenever parents and caregivers need it,” said FDA Commissioner Robert Califf. Roughly 40% of baby formula products are out of stock nationwide, data shows.
Last week, the White House eased import requirements and announced an effort to transport baby milk from abroad dubbed ‘Operation Fly Formula’. The US normally produces 98% of the infant formula it consumes, with imports mainly coming from Mexico, Ireland and the Netherlands. Companies seeking to enter the US market face formidable hurdles, such as rigorous research and manufacturing standards imposed by the FDA.
On Sunday, a military plane carrying enough powdered milk to fill half a million baby bottles arrived in the US from Germany. The delivery of the Nestle-made formula is expected to cover about 15% of the nationwide shortage.
The baby formula shortage began to take hold in the US last year amid supply chain issues caused by the pandemic. However, the situation deteriorated in February when Abbott Laboratories, one of the nation’s main manufacturers, recalled some of its products and shut down a manufacturing plant after four babies who had been fed formula made at the facility contracted a rare bacterial infection. Two of them later died.
Abbott said last week that after investigations by the FDA, Centers for Disease Control and Prevention (CDC) and by the company itself, no conclusive evidence was found to link its formulas to those incidents. The plant is now set to reopen in early June.
For more stories on economy & finance visit RT’s business section
